Amarin | Beban Penjualan Dan Administrasi



Selling And Administration Expenses Perubahan Tanggal
AbbVie USD 3.29B 562M 2025-03
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
Amarin USD 36.9M 1.64M 2024-09
AstraZeneca USD 3.59B 1.96B 2025-03
DBV Technologies USD 6.24M 1.32M 2024-09
GlaxoSmithKline GBP 2.06B 603M 2025-03
Halozyme Therapeutics USD 42.25M 1.01M 2024-12
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
Neurocrine Biosciences USD 287.8M 53.5M 2024-12
Novartis USD 3.5B 368M 2024-12



Amarin Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - May 2025.